SCHEMBL9908110

SCHEMBL9908110

CC(C)CC(C(=O)Nc1cnccn1)N1C(=O)C(=O)c2cc(Cl)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.47
RAB9A P51151 4/20 0.43
POLB P06746 3/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 6/20 0.42
MEN1 O00255 4/20 0.42
GCK P35557 4/20 0.41
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.39
THRB P10828 1/20 0.39
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ATM Q13315 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9107161 1.00 FFAR2 (0.47) FFAR2RAB9APOLBKDM4EMAPT
SCHEMBL9908115 0.94 FFAR2 (0.48) FFAR2RAB9APOLBKDM4EMAPT
SCHEMBL9107804 0.94 FFAR2 (0.48) FFAR2RAB9APOLBKDM4EMAPT
SCHEMBL9106920 0.90 GCK (0.44) FFAR2RAB9AKDM4EKMT2AGCK
SCHEMBL9908102 0.90 GCK (0.44) FFAR2RAB9AKDM4EKMT2AGCK
SCHEMBL9908096 0.89 GCK (0.41) FFAR2RAB9AKMT2AGCKNPC1
SCHEMBL9106938 0.89 GCK (0.41) FFAR2RAB9AKMT2AGCKNPC1
SCHEMBL9908092 0.88 KDM4E (0.43) FFAR2RAB9APOLBKDM4EKMT2A
SCHEMBL9105850 0.88 KDM4E (0.43) FFAR2RAB9APOLBKDM4EKMT2A
SCHEMBL9103795 0.88 FFAR2 (0.46) FFAR2RAB9APOLBMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT FFAR2 627/4885RAB9A 1778/4885POLB 3911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.